Amlodipine Besylate/Perindopril Arginine

Medicare and Medicare Advantage reimbursement status was recently obtained for ActiGraft PRO, enabling the wound care industry's most advanced whole-blood wound care solution to be purchased by wound care centers and practitioners nationally TEL AVIV, Israel and JACKSONVILLE, Fla., Aug. 22, 2023 /PRNewswire/ -- RedDress, developers of the ActiGraft PRO system, a personalized and autologous wound care solution created from patients' own whole blood, today announced that its ActiGraft PRO product is now available through Vizient, the nation's largest provider-driven healthcare performance improvement company. RedDress secured an Innovative Technology contract with Vizient in October 2022 and G-Code reimbursement status from Medicare and Medicare Advantage in July 2023. The agreement with Vizient now provides increased access to ActiGraft PRO to Vizient's customer base, which comprises academic medical centers, community hospitals, integrated health delivery networks and non-acute health care providers. Vizient's Innovative Technology contracts are recommended after review and interaction with products submitted through Vizient's Innovative Technology Program. Vizient customer-led councils identify technologies that have the potential to enhance clinical care, patient safety, healthcare worker safety or improve business operations of healthcare organizations. "We are excited for the momentum we are experiencing since obtaining Medicare reimbursement status and are thrilled to make ActiGraft PRO now available to wound care specialists nationally through Vizient," said Alon Kushnir, CEO and Co-Founder of RedDress. "Autologous, blood-based therapies are the future of wound care, and with ActiGraft PRO as the leading solution in the category, our contract with Vizient will significantly increase access to advanced wound care for patients and healthcare providers." The ActiGraft PRO system is an autologous, point-of-care wound management solution created from patient's whole blood. Once applied, the blood clot serves as a protective covering and optimizes the body's own healing potential. ActiGraft PRO is designed to jump-start wound healing and to meet the needs of today's high-volume practices and centers, offering practitioners a wound healing solution that delivers a quick, easy, and clean procedure. Applied directly to the wound surface, the ActiGraft PRO blood clot is created at the patient's bedside in under five minutes by mixing fresh whole blood with our proprietary coagulation powder. ActiGraft PRO contains whole blood cells including white cells, red cells, plasma, platelets, and fibrin, in the optimal concentration required in the wound healing process. Once applied, ActiGraft PRO reignites the healing cascade, serving as a protective covering that supports wound healing processes which occur naturally in the body. While reimbursement for ActiGraft PRO currently applies only to diabetic patients with lower extremity, non-pressure injury chronic wounds, ActiGraft PRO can be used for a wide variety of chronic wounds including but not limited to: Diabetic and Neuropathic Ulcers, Venous Ulcers, Traumatic Wounds, Post-Surgical Wounds, Skin Tears and Surgical Wounds. Since RedDress received FDA clearance and a CE Mark in 2020, ActiGraft has helped over 6,000 patients across the spectrum of healthcare facilities in the United States and 30 other countries. Disclaimer: The information provided shall not be constructed as a statement, promise, or guarantee that reimbursement will be received. Reimbursement requirements are subject to change at any time. Check with your local payer regularly. About RedDress RedDress is the leading provider of personalized and autologous wound management solutions created from patients own blood. The company's suite of ActiGraft products are transforming wound care, treating a wide variety of chronic wounds including diabetic and neuropathic ulcers, venous ulcers, pressure injuries, traumatic wounds, post-surgical wounds, skin tears, surgical wounds and more. ActiGraft PRO, the company's most advanced wound care product is exclusively available in the US. The ActiGraft wound care system is available internationally only, already commercially available in 30 countries across five continents. RedDress is a privately held, Israel-based company with a U.S. subsidiary, RedDress Inc., located in Jacksonville, Florida. Founded in 2009 with the goal of developing more effective, natural, and economically viable treatments for chronic wounds, RedDress is dedicated to using its whole-blood technology to find solutions to other human ailments. For more information, please visit SOURCE RedDress

ATLANTA, June 20, 2023 /PRNewswire/ -- Cascade Animal Sciences, an animal health start-up based in the United States and Australia, is proud to announce the launch of its first dietary supplement product "Neuro-Pro". Neuro-Pro is designed for middle-to-senior-aged dogs and dogs that require neurological support. It is added to their regular feed and contains a medium-chain triglyceride (MCT) formulation that acts as an alternative fuel source for the brain and has anti-inflammatory effects. Thanks to modern veterinary medicine and improved home care, dogs are living longer than ever before. However, as dogs age, they can experience a decline in cognitive function, affecting their day-to-day quality of life. This reduction in quality of life can be equally distressing for owners as it is for dogs. "Even with the growing awareness of geriatric care and neurological disorders in veterinary medicine through landmark projects like the Dog Aging Project", said Dr. Alice Edwards, Chief Veterinary Officer and a founder at Cascade "cognitive decline is still overlooked by many due to its subtle and gradual process. We hope to shine a further spotlight on this to ensure a better quality of life for dogs." Neuro-Pro's liquid formulation leverages the latest research in biochemistry and canine nutrition, containing decanoic (C10) and octanoic (C8) MCTs, which have anti-inflammatory effects on the brain and provide it with an alternative energy source, respectivel, as demonstrated in Image 1 below. . MCT-enriched diets have been shown to improve 5-out-of-6 measurements of cognitive decline in dogs within 30 days of commencement, with significant improvement across all measurements after 90 days. Furthermore, studies have demonstrated the benefits of MCTs linked to energy metabolism in dogs with epilepsy. In a 2021 study that examined the cognitive abilities of dogs with epilepsy, significant improvements in spatial working memory, problem-solving abilities, and owner trainability were observed secondary to the use of MCTs. In that regard, Cascade will also work with the veterinary industry in using MCTs as a means to support the cognitive health of dogs with epilepsy and to reduce the side of effects anti-epileptic drugs. According to Dr. Sean Hughes, a biochemist by training and Cascade's Chief Scientific Officer, "The brain is a highly energy-dependent organ that requires a constant supply of energy to function. Unfortunately, as dogs age, it is believed that their brains become less efficient at using glucose as an energy source, which can lead to a decline in cognitive function and quality of life." Dr Hughes added, "In addition to crossing the blood-brain barrier and being metabolised, the C10 fatty acids in Neuro-Pro provide neuronal anti-inflammatory effects. Neuro-Pro's formulation also contains C8 triglycerides, which, once metabolised, provide an alternative energy source for the brain in the form of ketones. This can help support overall brain health and play a role in preserving cognitive function." MCT-enriched diets in dogs and humans mimic some of the well-documented neurological and metabolic benefits of a ketogenic diet and fasting (such as those mentioned above). However, in contrast to MCT supplementation, ketogenic diets and fasting have inflexible, unsustainable, and sometimes dangerous requirements. Regarding the need for easy-to-incorporate tools that are preventative and support cognitive health in dogs, Dr. Edwards noted that "Cascade's sole focus is to provide veterinarians and dog owners with a simple way to achieve better brain health - and thereby improved quality of life. We see Neuro-Pro as a game changer for dog owners as it can be easily incorporated into a dogs' preferred diet, meaning that owners do not need to overhaul their feeding regime. We are thrilled to bring this to market and to offer a new way to support both canine neurological health and quality of life, particularly for senior dogs." About Neuro-Pro: Neuro-Pro is suitable for use in dogs of all breeds and sizes and comes in an easy-to-administer liquid formulation that is added to regular feed. It is available for sale in the USA directly from Cascade's website () and to Australia and the U.K. through international shipping. About Cascade Animal Sciences: Cascade Animal Sciences is an animal health company focused on making cognitive health in dogs more accessible, through dietary supplements such as its flagship product "Neuro-Pro". Media Contact: Tim Gibney, Cascade Animal Sciences (+614 38078 245); [email protected] SOURCE Cascade Animal Sciences